Constitutive reduction in the checkpoint inhibitor, CTLA-4, does not accelerate SLE in NZM 2328 mice

por Stohl, William, Yu, Ning, Chalmers, Samantha A, Putterman, Chaim, Jacob, Chaim O
Publicado 2019

The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus

por Moore, Erica, Huang, Michelle W., Jain, Shweta, Chalmers, Samantha A., Macian, Fernando, Putterman, Chaim
Publicado 2020

B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus

por Wen, Jing, Doerner, Jessica, Chalmers, Samantha, Stock, Ariel, Wang, Haowei, Gullinello, Maria, Shlomchik, Mark J., Putterman, Chaim
Publicado 2016

COVID-19 Infection Among Healthcare Workers: Serological Findings Supporting Routine Testing

por Stock, Ariel D., Bader, Edward R., Cezayirli, Phillip, Inocencio, Julio, Chalmers, Samantha A., Yassari, Reza, Yanamadala, Vijay, Eskandar, Emad
Publicado 2020

Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice

por Chu, Seung Y., Pong, Erik, Bonzon, Christine, Yu, Ning, Jacob, Chaim O., Chalmers, Samantha A., Putterman, Chaim, Szymkowski, David E., Stohl, William
Publicado 2020

TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus

por Doerner, Jessica, Wen, Jing, Xia, Yumin, Paz, Karin Blecher, Schairer, David, Wu, Lan, Chalmers, Samantha A., Izmirly, Peter, Michaelson, Jennifer S., Burkly, Linda C., Friedman, Adam, Putterman, Chaim
Publicado 2015

Highly selective inhibition of Bruton’s tyrosine kinase attenuates skin and brain disease in murine lupus

por Chalmers, Samantha A., Wen, Jing, Doerner, Jessica, Stock, Ariel, Cuda, Carla M., Makinde, Hadijat M., Perlman, Harris, Bosanac, Todd, Webb, Deborah, Nabozny, Gerald, Fine, Jay S., Klein, Elliott, Ramanujam, Meera, Putterman, Chaim
Publicado 2018

Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton’s Tyrosine Kinase

por Chalmers, Samantha A., Doerner, Jessica, Bosanac, Todd, Khalil, Sara, Smith, Dustin, Harcken, Christian, Dimock, Janice, Der, Evan, Herlitz, Leal, Webb, Deborah, Seccareccia, Elise, Feng, Di, Fine, Jay S., Ramanujam, Meera, Klein, Elliott, Putterman, Chaim
Publicado 2016

The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses

por Chalmers, Samantha A., Ayilam Ramachandran, Rajalakshmy, Garcia, Sayra J., Der, Evan, Herlitz, Leal, Ampudia, Jeanette, Chu, Dalena, Jordan, Nicole, Zhang, Ting, Parodis, Ioannis, Gunnarsson, Iva, Ding, Huihua, Shen, Nan, Petri, Michelle, Mok, Chi Chiu, Saxena, Ramesh, Polu, Krishna R., Connelly, Stephen, Ng, Cherie T., Mohan, Chandra, Putterman, Chaim
Publicado 2022

3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine

por Clement, Cristina C., D’Alessandro, Angelo, Thangaswamy, Sangeetha, Chalmers, Samantha, Furtado, Raquel, Spada, Sheila, Mondanelli, Giada, Ianni, Federica, Gehrke, Sarah, Gargaro, Marco, Manni, Giorgia, Cara, Luisa Carlota Lopez, Runge, Peter, Tsai, Wanxia Li, Karaman, Sinem, Arasa, Jorge, Fernandez-Rodriguez, Ruben, Beck, Amanda, Macchiarulo, Antonio, Gadina, Massimo, Halin, Cornelia, Fallarino, Francesca, Skobe, Mihaela, Veldhoen, Marc, Moretti, Simone, Formenti, Silvia, Demaria, Sandra, Soni, Rajesh K., Galarini, Roberta, Sardella, Roccaldo, Lauvau, Gregoire, Putterman, Chaim, Alitalo, Kari, Grohmann, Ursula, Santambrogio, Laura
Publicado 2021